Delayed Hemolytic Transfusion Reaction, anti-LebH

Status: 
Ready to upload
Record number: 
1741
Adverse Occurrence type: 
MPHO Type: 
Estimated frequency: 
N/A
Time to detection: 
12 days
Alerting signals, symptoms, evidence of occurrence: 
An 83-year-old female was admitted with rectal bleeding. After demonstrating a bleeding site in the ascending colon, a colectomy was performed. She was group B, Rh-positive, and no unexpected antibodies were detected in her serum. During surgery and in the immediate postoperative period, she received 14 units of red blood cells (RBC). Twelve days after transfusion, she developed fever, followed by gross hemoglobinuria. The significance of the clinical picture was not initially recognized. She again required blood, at which time she had a weakly positive direct antiglobulin test specific for complement. Antibodies to LebH and anti-E were demonstrated in her serum with a possible anti-K also present. The patient was given E- and K-negative units with almost immediate severe hemolysis manifested by gross hemoglobinuria, anemia, spherocytosis, depressed serum haptoglobin, and elevated plasma free hemoglobin. The patient was subsequently transfused with red cells negative for E, K and Leb antigens. The patient was closely observed and no signs of hemolysis were noted.
Demonstration of imputability or root cause: 
The patient suffered from two evident hemolytic episodes, one delayed and the other one in the form of an immediate hemolytic acute reaction. Only a new potential transfusion reaction was prevented when the patient received RBC that were negative for E, K and LebH antigens.
Imputability grade: 
3 Definite/Certain/Proven
Groups audience: 
Suggest references: 
Weir III AB, Lee L, Chesney C, Neitzer G. (1987). Delayed Hemolytic Transfusion Reaction Caused by anti-LebH Antibody. Vox Sang 53:105-107.
Expert comments for publication: 
This is the first reported case of a serious delayed hemolytic transfusion reaction caused by anti-LebH antibody. Currently, testing for Lewis antigens on red cells of blood units that are compatible with Lewis antibodies reacting only at temperatures below 37ºC is not recommended. Based on the experience with this case it was established a surveillance policy to monitor the results of transfusion when blood units are not tested for antigens against antibodies not thought to be clinically significant.